Aurora Cannabis Inc. (ACB)
Market Cap | 259.14M |
Revenue (ttm) | 200.73M |
Net Income (ttm) | -107.70M |
Shares Out | 15.73M |
EPS (ttm) | -3.91 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 9,809,349 |
Open | 4.640 |
Previous Close | 4.750 |
Day's Range | 4.300 - 4.990 |
52-Week Range | 2.840 - 11.500 |
Beta | 2.83 |
Analysts | Hold |
Price Target | 9.00 (+105.01%) |
Earnings Date | May 15, 2024 |
About ACB
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, th... [Read more]
Full Company ProfileFinancial Performance
In 2022, ACB's revenue was 221.34 million, a decrease of -9.75% compared to the previous year's 245.25 million. Losses were -1.72 billion, 147.2% more than in 2021.
Financial numbers in CAD Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for ACB stock is "Hold." The 12-month stock price forecast is $9.0, which is an increase of 105.01% from the latest price.
News
Tilray and Aurora Cannabis stocks are flying but it's risky to buy
Cannabis stocks are surging, helped by positive regulatory steps in the United States. Tilray Brands (NASDAQ: TLRY) stock jumped to $2.4 in the pre-market, its highest level since January 9th of this ...
Pot Stocks: The Mary Jane Trade Is Lit
Cannabis stocks traded higher today as Germany approved partial legalization. Adults would be able to carry up to 25G of cannabis in public.
Cannabis stocks fall but hold onto big gains from the week on brighter federal reform prospects
Cannabis stocks cooled off Thursday but held onto big gains from the past week on the heels of positive comments from the Biden administration on reclassifying cannabis from a Schedule I controlled su...
Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance
Milestone Achievement Signals Company's Commitment to Solidifying its Leadership in the Australian Market NAS...
Aurora Cannabis, Canopy Growth, Curaleaf stocks spiked: here's why
It is a good Monday for Cannabis stocks. Canopy Growth (CGC), Curaleaf (CURLF), and Aurora Cannabis (ACB) stock prices surged by more than 10% in the pre-market session.
Cannabis stocks rise after President Biden mentions plant in State of the Union speech
Shares of both U.S. and Canadian cannabis stocks moved up on Friday after President Joe Biden mentioned the federal government's current effort to potentially reclassify the plant under federal law in...
Top Marijuana Stocks For Trading Today 2024
More publicly traded cannabis companies are starting to report earnings. This alone has been another reason shareholders have seen a slight increase in trading momentum for marijuana stocks. Speculati...
Cannabis Earnings Off To A Great Start
It's great to see GTI deliver a very solid quarter, notes Morgan Paxhia. He and Matt Hawkins discuss the takeaways from the latest cannabis earnings.
Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia
NASDAQ | TSX: ACB Canada's Leading Medical Cannabis Company and MedReleaf Australia Launch Innovative Product to Offer Greater Choice for Patients EDMONTON, AB , March 4, 2024 /PRNewswire/ - Aurora Ca...
Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1]
NASDAQ | TSX: ACB EDMONTON, AB , Feb. 29, 2024 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canada-based leading global medical cannabis company, today...
Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis
NASDAQ | TSX: ACB Partnership will empower UK patients with valuable information and guidance critical to a successful cannabis experience EDMONTON, AB , Feb. 28, 2024 /PRNewswire/ - Aurora Cannabis...
3 Canadian Marijuana Stocks To Start The New Week
People who are involved in cannabis investing are keeping a positive outlook towards the future. Many feel this year will be big for investors and have the potential to see a rise in marijuana stocks....
Cannabis stocks rise as Germany takes ‘first big step' toward broader legalization in Europe
Curaleaf Holdings Inc. Executive Chairman Boris Jordan and other cannabis executives on Friday praised Germany's removal of cannabis from a list of narcotics as a potential boost to the marijuana busi...
Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation
NASDAQ | TSX: ACB EDMONTON, AB , Feb. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, is ...
Cannabis Investing: Are Big Gains Coming For These Marijuana Stocks?
Investors are working on various strategies to see returns from their marijuana stock investments. As most who are active in the sector can see the upward momentum is not consistent. Much of the way c...
Leading Canadian Cannabis Stock Powers Through with Strong Weekly Momentum
In February 2024, top Canadian cannabis stocks showed mixed performance amid evolving market dynamics. Companies like Canopy Growth, Aurora Cannabis, and Tilray Brands remained focal points for invest...
Aurora Cannabis just bought MedReleaf Australia: find out more
Aurora Cannabis Inc (NASDAQ: ACB) is in focus today after buying the remaining 90% stake in MedReleaf Australia for about AU$50 million ($32.45 million). Details of Aurora-MedReleaf transaction The li...
Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million
NASDAQ | TSX: ACB Re-Affirms Commitment to Achieving Positive Free Cash Flow 1 This Calendar Year, Delivers Fifth Consecutive Quarter of Positive Adjusted EBITDA 1 Aurora Becomes the Largest Global M...
Aurora Cannabis Acquires MedReleaf Australia
NASDAQ | TSX: ACB Aurora becomes the largest global medical cannabis company operating in nationally legal markets. MedReleaf Australia holds the #2 position in medical cannabis within the rapidly gro...
Aurora Cannabis Provides Business Update and Announces Date of Third Quarter Fiscal Year 2024 Investor Conference Call
NASDAQ | TSX: ACB Re-affirms expectation of positive annual Adjusted EBITDA1 for fiscal 2024 and Positive Free Cash Flow1 generation in calendar 2024 Announces Intention to Consolidate Common Shares Q...
Aurora Unveils Innovative Cannabis-Infused Ready-to-Drink Beverage in Latest Medical Product Launch
NASDAQ | TSX: ACB Available at launch exclusively to Aurora's veteran patients, new products span THC, CBD and CBG offerings to meet the discerning taste, experience and product variety patients seek...
Cultivating Wealth: 2024's Top Cannabis ETFs for Long Term Investors
Cannabis ETFs are garnering attention in 2024 as the industry shows promising growth. Key players like MJ, MSOS, and CNBS dominate this sector. These ETFs offer diversified exposure to cannabis-relate...
Navigating Canadian Cannabis: Top Stocks for Q1 2024
As we delve into Q1 2024, the Canadian cannabis market and its top marijuana stocks continue to captivate investors' attention. This sector, a trailblazer due to Canada's early legalization, is buzzin...
Cannabis stocks: What investors need to know about regulation in the U.S. market
On the backdrop of cannabis company Tilray (TLRY) — which is traded on the Nasdaq (^IXIC) but operates primarily in Canada — reporting record revenues in its fiscal second quarter of 2024, what are th...
Cannabis stocks mark second day of gains as DEA confirms its review of marijuana's Schedule I classification
Cannabis stocks are notching their second day of gains after the Drug Enforcement Administration confirmed it's reviewing an August recommendation from the U.S. Department of Health and Human Services...